Berlin-based 80 Beats Medical has secured €2.4 million in seed financing to advance its noninvasive cardiovascular assessment for women. The funding combines private investment and non-dilutive public financing.
The company has developed Vicorder, a portable vascular diagnostic system that works with commonly used sensors, including blood pressure cuffs, to measure cardiovascular markers within minutes.
With cardiovascular disease remaining the leading cause of death in women, 80 Beats plans to employ the technology across key life stages to support earlier detection and long-term health outcomes.
The company is initially targeting pregnancy, where assessments of maternal hemodynamics could help identify women at risk of complications earlier and inform clinical decisions.
The funding will support continued product development, research, and eventual commercialization of the Vicorder-based platform.
